NextPharma Tampere has several decades of extensive experience and a proven track record in pharmaceutical development, commercial manufacturing and commercial packaging of ophthalmic products either in Blow fill seal uni or multidose, 3P bottles or PFMD devices.
Joining NextPharma in 2019, the team was able from the beginning to fully comply with CDMO services with constant professionalism, reactivity associated to strong Project Management and customer dedication.
- Pharmaceutical formulation development
- Scale-up (pilot-scale, production-scale)
- Manufacturing of stability batches
- Galenic optimisation of existing formulae
- Registration services
- Analytical development
- Stability testing / storage
- Quality control
- Market release
|3P bottles||40 Mio bottles|
|BFS single dose||3,2 Mio ampoule stripes (10)|
|BFS multi dose||8 Mio bottles|
|Regulatory status||EMA, FDA (USA), audited by Russian authorities|